Opening Question Could psilocybin therapy offer hope for people with bipolar 2 depression who have been excluded from most psychedelic research due to safety concerns? A groundbreaking new study suggests that psilocybin-assisted therapy might be both safe and effective for this underserved population, potentially opening...
Opening Question Could a nasal spray be the breakthrough that millions of people with treatment-resistant depression have been waiting for? The FDA's recent approval of Spravato (esketamine) as a standalone treatment marks a historic moment in mental health care—but what do the clinical trial results...
What question is this article answering? What are the most effective, evidence-based treatment protocols for managing psychedelic-induced psychosis and HPPD (Hallucinogen Persisting Perception Disorder), and how can clinicians safely help patients who experience persistent adverse effects from psychedelic use? Synopsis: Recent clinical research has identified...
What question is this article answering? Is microdosing 5-MeO-DMT—often called the "God molecule"—actually safe, and what do the latest clinical trials tell us about the risks and benefits of this powerful psychedelic? Synopsis: Groundbreaking Phase 1 clinical trials have demonstrated that microdosing 5-MeO-DMT is remarkably...